SCHEMBL8674429

SCHEMBL8674429

CC1(C)CC(CNC(=O)CI)C(C)(C)N1[O]

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 1/20 0.33
ADORA1 P30542 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2049553 0.84 ADORA3 (0.33) ADORA3ADORA1
SCHEMBL26083197 0.84 GAA (0.38)
SCHEMBL2027509 0.75 MAOB (0.30)
SCHEMBL2025665 0.74 MAOB (0.33)
SCHEMBL2024934 0.73 CYP3A4 (0.30)
SCHEMBL6558986 0.71 ADORA3 (0.32) ADORA3ADORA1
SCHEMBL1933227 0.70 MAOB (0.48)
SCHEMBL2992832 0.70 ADORA3 (0.36) ADORA3ADORA1
SCHEMBL28621104 0.69 GAA (0.38)
SCHEMBL9345395 0.67 ADORA3 (0.34) ADORA3ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180074079-A1 COMPOSITIONS AND METHODS TO ASSESS THE CAPACITY OF HDL TO SUPPORT REVERSE CHOLESTEROL TRANSPORT CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND (US) 2018-03-15 US claimed
US-20160305967-A1 COMPOSITIONS AND METHODS TO ASSESS THE CAPACITY OF HDL TO SUPPORT REVERSE CHOLESTEROL TRANSPORT CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND 2016-10-20 US claimed
US-20140162376-A1 COMPOSITIONS AND METHODS TO ASSESS THE CAPACITY OF HDL TO SUPPORT REVERSE CHOLESTEROL TRANSPORT NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2014-06-12 US claimed
EP-2702400-A2 COMPOSITIONS AND METHODS TO ASSESS THE CAPACITY OF HDL TO SUPPORT REVERSE CHOLESTEROL TRANSPORT Children's Hospital & Research Center at Oakland (US) 2014-03-05 EP claimed
WO-2012149473-A2 COMPOSITIONS AND METHODS TO ASSESS THE CAPACITY OF HDL TO SUPPORT REVERSE CHOLESTEROL TRANSPORT CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND (US) 2012-11-01 WO claimed
US-5714510-A Topical proxyl composition and method PROCTOR PETER H (US) 1998-02-03 US claimed
EP-0327263-B1 Hair growth stimulation with nitroxide and other radicals PROCTOR PETER H (US) 1994-09-07 EP claimed
WO-1988005653-A1 TOPICAL COMPOSITION FOR STIMULATING HAIR GROWTH WITH STABLE FREE RADICALS PROCTOR PETER H (US) 1988-08-11 WO claimed
US-20180074079-A1 COMPOSITIONS AND METHODS TO ASSESS THE CAPACITY OF HDL TO SUPPORT REVERSE CHOLESTEROL TRANSPORT CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND (US) 2018-03-15 US disclosed
US-20160305967-A1 COMPOSITIONS AND METHODS TO ASSESS THE CAPACITY OF HDL TO SUPPORT REVERSE CHOLESTEROL TRANSPORT CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND 2016-10-20 US disclosed
US-20140162376-A1 COMPOSITIONS AND METHODS TO ASSESS THE CAPACITY OF HDL TO SUPPORT REVERSE CHOLESTEROL TRANSPORT NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2014-06-12 US disclosed
EP-2702400-A2 COMPOSITIONS AND METHODS TO ASSESS THE CAPACITY OF HDL TO SUPPORT REVERSE CHOLESTEROL TRANSPORT Children's Hospital & Research Center at Oakland (US) 2014-03-05 EP disclosed
WO-2012149473-A2 COMPOSITIONS AND METHODS TO ASSESS THE CAPACITY OF HDL TO SUPPORT REVERSE CHOLESTEROL TRANSPORT CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND (US) 2012-11-01 WO disclosed
US-5714510-A Topical proxyl composition and method PROCTOR PETER H (US) 1998-02-03 US disclosed
EP-0327263-B1 Hair growth stimulation with nitroxide and other radicals PROCTOR PETER H (US) 1994-09-07 EP disclosed
WO-1988005653-A1 TOPICAL COMPOSITION FOR STIMULATING HAIR GROWTH WITH STABLE FREE RADICALS PROCTOR PETER H (US) 1988-08-11 WO disclosed